Adcetris
Adcetris ingredients
| Active ingredient | Strength |
|---|---|
| Brentuximab Vedotin | 50 mg/10.5mL |
What Adcetris is used for
The FDA lists the approved uses on the official label (below). In the EU, brentuximab vedotin is approved as Adcetris for:
Hodgkin lymphomaAdcetris is indicated for adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma (HL) in combination with doxorubicin, vinblastine and dacarbazine (AVD).Adcetris is indicated for adult patients with previously untreated CD30+ Stage IIB with risk factors, Stage III or Stage IV HL in combination with etoposide, cyclophosphamide, doxorubicin, dacarbazine, dexamethasone (BrECADD).Adcetris is indicated for the treatment of adult patients with CD30+ HL at increased risk of relapse or progression following autologous stem cell transplant (ASCT).Adcetris is indicated for the treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL):- following ASCT, or- following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option.Systemic anaplastic large cell lymphomaAdcetris in combination with cyclophosphamid…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Adcetris
- Generic name
- Brentuximab vedotin
- Made by
- SEAGEN INC.
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous
- Drug class
- CD30-directed Immunoconjugate
- FDA approval
- Biologic licence (BLA) BLA125388
- On the US market since
- 2011
Official information
- Adcetris prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Brentuximab vedotin)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Adcetris?
Adcetris (Brentuximab vedotin) is a cancer medicine made by SEAGEN INC., approved by the US FDA.
What are the ingredients of Adcetris?
Adcetris contains Brentuximab Vedotin (50 mg/10.5mL).
Is Adcetris approved in Europe?
The same active substance is approved in the EU as Adcetris.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA